THE INNOVATIVE MEDICINES INITIATIVE
The Innovative Medicines Initiative (IMI) is Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients.
IMI supports collaborative research projects and builds networks of industrial and academic experts in order to boost pharmaceutical innovation in Europe.
IMI is a joint undertaking between the European Union and the pharmaceutical industry association EFPIA.
IMI LAUNCHES EBOLA+ PROGRAMME
IMI has launched an ambitious programme to accelerate the development of vaccines and treatments against Ebola and related diseases. The first Call under the Ebola+ programme has a total budget of €280m.
- 21/11/2014 : RT @DIRECTdiabetes: Fantastic open house at Lund diabetes centre. 93 DIRECT participants came to talk about #diabetes #research and have up…
- 20/11/2014 : RT @eupatients: European Pharma - very active on Twitter! http://t.co/XvaT0vlsop
- 19/11/2014 : RT @DIRECTdiabetes: Our researchers at Lund are getting ready to welcome participants to open house tomorrow! Great chance to hear more abo…